Evidence map›Paper›PMID 34471522›Full record

ReviewClinical kidney journal2021

Kidney involvement in multisystem inflammatory syndrome in children: a pediatric nephrologist's perspective.

Sidharth Kumar Sethi, Abhyuday Rana, Harsha Adnani, Mignon McCulloch, Khalid Alhasan, Azmeri Sultana, Rama Safadi, Nirav Agrawal, Rupesh Raina

Abstract readReview
In one paragraph

Review in Clinical kidney journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sidharth Kumar SethiDivision of Pediatric Nephrology, Kidney Institute, Medanta, The Medicity, Gurgaon, Haryana, India.
Abhyuday RanaKidney Institute, Medanta, The Medicity, Gurgaon, Haryana, India.
Harsha AdnaniFeinstein Institute for Medical Research, Northwell Health, Manhasset, NY, USA.
Mignon McCullochDepartment of Renal and Organ Transplant, Red Cross War Memorial Children's Hospital, Rondebosch, Cape Town, South Africa.
Khalid AlhasanPediatric Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Azmeri SultanaPediatric Nephrology, M R Khan Children Hospital, and Institute of Child Health, Dhaka, Bangladesh.
Rama SafadiAkron Nephrology Associates/Cleveland Clinic Akron General Medical Center, Akron, OH, USA.
Nirav AgrawalFeinstein Institute for Medical Research, Northwell Health, Manhasset, NY, USA.
Rupesh RainaAkron Nephrology Associates/Cleveland Clinic Akron General Medical Center, Akron, OH, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The initial report of the multisystem inflammatory syndrome in children (MIS-C) was from the UK in April 2020; since then, cases have been reported worldwide. Renal involvement has been seen commonly, ranging from 10% to 46%. Kidney involvement following severe acute respiratory syndrome coronavirus 2 infection in children with MIS-C is more common than initially thought and is associated with higher morbidity and mortality. There are several reports of a direct viral tropism of coronavirus disease 2019 and MIS-C-associated renal damage. This study's objective was to systematically review the current understanding of kidney involvement in children suffering from MIS-C. Based on our systemic literature search, 19 studies have either partially or fully discussed kidney involvement in MIS-C patients. Furthermore, we discuss the multifactorial pathogenesis contributing to acute kidney injury (AKI) development in MIS-C. The current review gives a pediatric nephrologist's perspective of the renal involvement in MIS-C, the incidence of AKI, the pathophysiology of AKI in MIS-C and the proposed therapeutic regimens available, including the need for kidney replacement therapy for a child with AKI associated with MIS-C. As the disease is rapidly evolving, more detailed clinical prospective studies are required to understand MIS-C and its role in AKI better.

Indexed as

acute kidney injuryCOVID-19MIS-Cnephrology

Identifiers

PMID34471522
PMCPMC8083308

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.